Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-2-11
|
pubmed:abstractText |
To clarify the role of the MEN1 gene in the tumorigenesis of sporadic adrenocortical tumors, we performed a molecular study on 35 adrenocortical lesions including 6 hyperplasias, 19 adenomas and 10 carcinomas. Loss of heterozygosity (LOH) of the MEN1 gene was assessed by PCR using an intragenic (D11S4946) and 2 flanking microsatellite markers (D11S4936, PYGM) and/or fluorescence in situ hybridization (FISH) with a 40-kb cosmid probe containing the MEN1 gene. The complete coding sequence of the MEN1 gene was screened for mutations using non-radioactive, PCR-based single-strand conformation polymorphism (SSCP) analysis and MDE heteroduplex gel electrophoresis. PCR-LOH and FISH analyses performed in 29 tumors (PCR-LOH in 4, FISH in 17 and both in 8 tumors) revealed allelic deletion of the MEN1 locus in 8 (27.5%) and at 11q13 in 9 (31%) tumors. Furthermore, the frequency of LOH at 11q13 was significantly higher in adrenocortical carcinomas (60%) than in benign lesions (11%). Mutation analysis of tumor samples revealed 9 polymorphisms in 7 tumors (S145S, R171Q, R171Q together with L432L) but no mutations, with the exception of one adrenocortical adenoma. The latter tumor contained a somatic E109X stop codon mutation in exon 2 and a 5178-9G-->A splice mutation in intron 4, which was also detectable in various nontumorous tissues and blood indicative of a germ-line mutation. The patient, who had no clinical signs or family history of MEN1, later also developed a neuroendocrine carcinoma (atypical carcinoid) of the lung. Our findings indicate that inactivating mutations of the MEN1 tumor-suppressor gene appear not to play a prominent role in the development of sporadic hyperplastic or neoplastic lesions of the adrenal cortex and that the newly reported 5178-9G-->A splice mutation in intron 4 might cause a variant of the MEN1 phenotype.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
373-9
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:9935177-Adrenal Cortex,
pubmed-meshheading:9935177-Adrenal Cortex Neoplasms,
pubmed-meshheading:9935177-Adrenocortical Adenoma,
pubmed-meshheading:9935177-Adrenocortical Carcinoma,
pubmed-meshheading:9935177-Adult,
pubmed-meshheading:9935177-Aged,
pubmed-meshheading:9935177-Aged, 80 and over,
pubmed-meshheading:9935177-Female,
pubmed-meshheading:9935177-Humans,
pubmed-meshheading:9935177-Hyperplasia,
pubmed-meshheading:9935177-Loss of Heterozygosity,
pubmed-meshheading:9935177-Male,
pubmed-meshheading:9935177-Middle Aged,
pubmed-meshheading:9935177-Neoplasm Proteins,
pubmed-meshheading:9935177-Polymerase Chain Reaction,
pubmed-meshheading:9935177-Polymorphism, Single-Stranded Conformational,
pubmed-meshheading:9935177-Proto-Oncogene Proteins
|
pubmed:year |
1999
|
pubmed:articleTitle |
MEN1 gene mutation analysis of sporadic adrenocortical lesions.
|
pubmed:affiliation |
Department of Pathology, University of Zurich, Switzerland.
|
pubmed:publicationType |
Journal Article
|